Antithrombotic Therapy in Atrial Fibrillation
- 1 October 1992
- Vol. 102 (4), 426S-433S
- https://doi.org/10.1378/chest.102.4_supplement.426s
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at RiskAnnals of Internal Medicine, 1992
- How Should Results from Completed Studies Influence Ongoing Clinical Trials?Annals of Internal Medicine, 1991
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990
- Risk Factors for Thromboembolic Complications in Chronic Atrial FibrillationArchives of Internal Medicine, 1990
- Prevalence of Cardiovascular Disease and Diabetes Mellitus in Residents of Rochester, MinnesotaMayo Clinic Proceedings, 1990
- PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATIONThe Lancet, 1989
- Chronic atrial fibrillation— epidemiologic features and 14 year follow-up: A case control studyEuropean Heart Journal, 1987
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982